SGX:P31 - Pharmesis Intl (SGD 0.035) PHARMESIS INTERNATIONAL LTD.
Sector: Health Technology, Industry: Pharmaceuticals: Generic

Add to WatchList

See related symbol BFK


Note: This stock seems to be inactive

SGD 0.035    +0.0 (+0%)
Show Technical Chart | 1M    3M    6M    1Y    3Y    5Y         

31 Aug 2015


Overview

31 Aug 2015

52 Wk Range: 0.021 - 0.057

Day's Range: 0.035 - 0.035

Last Volume: 0

Current Yield: 0%

Projected Yield: 0%

Future Yield: [Friends Only]

Dividend Strength: [Friends Only]


Metric P31 S.Median
Beta NA NA
VaR NA NA
E.Shortfall NA NA
Liquidity NA NA

Fundamental


More from SGX

General

CEO: Xue Dan Wu

Founded Year: 2003

Headquarters: Chengdu

Security Type: Stock

Useful Links
Homepage

Description

Pharmesis International Ltd. Is an investment holding company, which engages in the research, development, production, sale, and marketing of medicine and medicine formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates through the following segments: Western Drugs, Traditional Chinese Medicine (TCM) Formulated Drugs, and Distribution. The Western Drugs segment involves in the chemically formulated drugs and is marketed under the Kinna brand. The TCM segment offers traditional Chinese medicine and is marketed under the Longlife brand. The Distribution segment consists of agency products and internally manufactured products which are marketed through the distribution arm. The company was founded on September 29, 2003 and is headquartered in Chengdu, China.